STTCOMP IBX FA LONG
- Health industry - cancer detection technology
- Market Cap $82m
- Sufficient cash for 2 years at current spend
- No news for a month (and likely EOFY selling) has caused the SP to slide
- Current SP 10.0c
IBX is slow on news however when news does arrive regarding trial progress it should have a markedly positive effect on the SP again, hopefully returning it to its recent high of 21c and potentially higher.
Will take some patience but for those with some spare $ now is a good time to put a little away.
Riesling
_________________
Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to find and detect cancer.
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 28 June
STTCOMP IBX FA LONGHealth industry - cancer detection...
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)